(Q37955283)

English

Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, Osaka Medical College regimen

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, Osaka Medical College regimen (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

bladder carcinoma

1 reference

based on heuristic

inferred from title

author name string

Haruhito Azuma

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Teruo Inamoto

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Kiyoshi Takahara

3

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Naokazu Ibuki

4

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Hayahito Nomi

5

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Kazuhiro Yamamoto

6

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Yoshihumi Narumi

7

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Takanobu Ubai

8

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

publication date

13 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

International Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

26-38

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Novel bladder preservation therapy for locally invasive bladder cancer: Combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Evaluation for surrogacy of end points by using data from observational studies: tumor downstaging for evaluating neoadjuvant chemotherapy in invasive bladder cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemoth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Radiotherapy with and without cisplatin in bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Combined-modality treatment and organ preservation in bladder cancer. Do molecular markers predict outcome?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Combined intraarterial chemotherapy and radiotherapy in the treatment of bladder carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Chemoradiotherapy as a bladder-preservation approach for muscle-invasive bladder cancer: current status and perspectives

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2011.02856.X

21 January 2018

Identifiers

10.1111/J.1442-2042.2011.02856.X

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

release_gafo3pm7tnhetaymyl6yffrozy

1 reference

https://api.fatcat.wiki/v0/release/gafo3pm7tnhetaymyl6yffrozy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37955283&oldid=2088635737"